These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37595665)

  • 21. Reduction-responsive amphiphilic polymeric prodrugs of camptothecin-polyphosphoester for cancer chemotherapy.
    Jin H; Sun M; Shi L; Zhu X; Huang W; Yan D
    Biomater Sci; 2018 May; 6(6):1403-1413. PubMed ID: 29595843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy.
    He X; Cai K; Zhang Y; Lu Y; Guo Q; Zhang Y; Liu L; Ruan C; Chen Q; Chen X; Li C; Sun T; Cheng J; Jiang C
    ACS Appl Mater Interfaces; 2018 Nov; 10(46):39455-39467. PubMed ID: 30362704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy.
    Zhang W; Hu X; Shen Q; Xing D
    Nat Commun; 2019 Apr; 10(1):1704. PubMed ID: 30979885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
    Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
    ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The self-assembling camptothecin-tocopherol prodrug: An effective approach for formulating camptothecin.
    Lu J; Liu C; Wang P; Ghazwani M; Xu J; Huang Y; Ma X; Zhang P; Li S
    Biomaterials; 2015 Sep; 62():176-87. PubMed ID: 26057133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-assembly delivery system based on small-molecule camptothecin prodrug for treatment of colorectal carcinoma.
    Dai J; Chen M; Xu D; Li H; Qiao Y; Ke X; Ci T
    Nanomedicine (Lond); 2021 Feb; 16(5):355-372. PubMed ID: 33591852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GSH/pH dual-responsive biodegradable camptothecin polymeric prodrugs combined with doxorubicin for synergistic anticancer efficiency.
    Li J; Hu ZE; Yang XL; Wu WX; Xing X; Gu B; Liu YH; Wang N; Yu XQ
    Biomater Sci; 2019 Aug; 7(8):3277-3286. PubMed ID: 31180396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous reactive oxygen species burst induced and spatiotemporally controlled multiple drug release by traceable nanoparticles for enhancing antitumor efficacy.
    Wang N; Liu C; Yao W; Zhou H; Yu S; Chen H; Qiao W
    Biomater Sci; 2021 Jul; 9(14):4968-4983. PubMed ID: 34085682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ATP-triggered mitochondrial cascade reactions for cancer therapy with nanoscale zeolitic imidazole framework-90.
    Pan W; Cui B; Wang K; Shi M; Lu F; Li N; Tang B
    Theranostics; 2021; 11(16):7869-7878. PubMed ID: 34335969
    [No Abstract]   [Full Text] [Related]  

  • 30. Carrier-free Janus nano-prodrug based on camptothecin and gemcitabine: Reduction-triggered drug release and synergistic in vitro antiproliferative effect in multiple cancer cells.
    Xu Y; Huang Y; Zhang X; Lu W; Yu J; Liu S
    Int J Pharm; 2018 Oct; 550(1-2):45-56. PubMed ID: 30138703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glutathione-Responsive Nanoparticles of Camptothecin Prodrug for Cancer Therapy.
    Zhang L; Zhu L; Tang L; Xie J; Gao Y; Yu C; Shang K; Han H; Liu C; Lu Y
    Adv Sci (Weinh); 2023 Jan; 10(3):e2205246. PubMed ID: 36442854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced cytotoxicity to lung cancer cells by mitochondrial delivery of camptothecin.
    Xie J; Wang H; Huang Q; Lin J; Wen H; Miao Y; Lv L; Ruan D; Yu X; Qin L; Zhou Y
    Eur J Pharm Sci; 2023 Oct; 189():106561. PubMed ID: 37562549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitochondria-Specific Anticancer Drug Delivery Based on Reduction-Activated Polyprodrug for Enhancing the Therapeutic Effect of Breast Cancer Chemotherapy.
    Wang Y; Zhang T; Hou C; Zu M; Lu Y; Ma X; Jia D; Xue P; Kang Y; Xu Z
    ACS Appl Mater Interfaces; 2019 Aug; 11(32):29330-29340. PubMed ID: 31329411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stimulus-Responsive Nano-Prodrug Strategies for Cancer Therapy: A Focus on Camptothecin Delivery.
    Chu B; Deng H; Niu T; Qu Y; Qian Z
    Small Methods; 2023 Dec; ():e2301271. PubMed ID: 38085682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A camptothecin prodrug induces mitochondria-mediated apoptosis in cancer cells with cascade activations.
    Luo X; Chi X; Lin Y; Yang Z; Lin H; Gao J
    Chem Commun (Camb); 2021 Oct; 57(84):11033-11036. PubMed ID: 34608474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ROS-responsive nanoparticles based on amphiphilic hyperbranched polyphosphoester for drug delivery: Light-triggered size-reducing and enhanced tumor penetration.
    Jin H; Zhu T; Huang X; Sun M; Li H; Zhu X; Liu M; Xie Y; Huang W; Yan D
    Biomaterials; 2019 Aug; 211():68-80. PubMed ID: 31096162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gemcitabine-camptothecin conjugates: a hybrid prodrug for controlled drug release and synergistic therapeutics.
    Hou M; Xue P; Gao YE; Ma X; Bai S; Kang Y; Xu Z
    Biomater Sci; 2017 Aug; 5(9):1889-1897. PubMed ID: 28681888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery.
    Li Y; Lu H; Liang S; Xu S
    ACS Appl Mater Interfaces; 2019 Jun; 11(23):20649-20659. PubMed ID: 31117440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug.
    Wu X; Sun X; Guo Z; Tang J; Shen Y; James TD; Tian H; Zhu W
    J Am Chem Soc; 2014 Mar; 136(9):3579-88. PubMed ID: 24524232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.